readthroughSign in
CompanyIMDXNasdaqNashville, TN

Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics develops molecular diagnostic tests including GraftAssureCore, GraftAssureIQ, GraftAssureDx, GraftAssure, DetermaIO, and DetermaCNI for transplant and immunology applications.

424B5Nov 16Latest SEC filing
Nov 16Latest story